ACT for Cancer

We work to empower patients and clinicians to explore novel cancer treatments and trials. Often called ‘novel’ ‘off-label’ or ‘compassionate-use’ drugs, these cancer treatments mainly exist outside of the usual standard of care or could be part of a clinical trial. But for patients who have exhausted the standard treatment options, these new treatments could provide: improved life chances to cancer patients; deeper clinical understanding for oncologists and researchers in how to better treat tumour types; evidence for mainstream adoption.